✦ LIBER ✦

Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma

✍ Scribed by Chawla, S. P.; Cranmer, L. D.; Van Tine, B. A.; Reed, D. R.; Okuno, S. H.; Butrynski, J. E.; Adkins, D. R.; Hendifar, A. E.; Kroll, S.; Ganjoo, K. N.

Book ID: 126631246
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 598 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2013.54.3660

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study with the combination of g

Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas

✍ R. Losa; J. Fra; A. López-Pousa; M. Sierra; A. Goitia; E. Uña; R. Nadal; J. Garc 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 402 KB

Combination of pegylated liposomal doxor

Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

✍ Bafaloukos, D; Papadimitriou, C; Linardou, H; Aravantinos, G; Papakostas, P; Ska 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

Temozolomide in adult patients with adva

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

✍ P.J Woll; I Judson; S.M Lee; S Rodenhuis; O.S Nielsen; J.M Buesa; P.C Lorigan; S 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Exatecan in pretreated adult patients wi

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma Group

✍ P. Reichardt; O.S. Nielsen; S. Bauer; J.T. Hartmann; P. Schöffski; T.B. Christen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Doxorubicin plus ifosfamide with rhGM-CS

Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group

✍ W. P. Steward; J. Verweij; R. Somers; G. Blackledge; M. Clavel; A. T. Van Ooster 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 561 KB

First-line treatment of metastatic or lo

First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study

✍ George D. Demetri; Axel Le Cesne; Sant P. Chawla; Thomas Brodowicz; Robert G. Ma 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 818 KB